bcl-2 and p21 immunostaining of cervical tubo-endometrial metaplasia.
McCluggage
W Glenn
WG
Maxwell
P
P
D015415:Biomarkers; D002584:Cervix Uteri / Q000378:metabolism / Q000473:pathology; D004715:Endometriosis / Q000378:metabolism* / Q000473:pathology; D004717:Endometrium / Q000378:metabolism / Q000473:pathology; D005187:Fallopian Tubes / Q000166:cytology / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008679:Metaplasia / Q000378:metabolism / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*; D016283:Proto-Oncogene Proteins p21(ras) / Q000096:biosynthesis*; D002577:Uterine Cervical Diseases / Q000378:metabolism* / Q000473:pathology
D015415:Biomarkers; D019253:Proto-Oncogene Proteins c-bcl-2; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)